Logan Capital Management Inc. Sells 978 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Logan Capital Management Inc. lowered its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 4.0% during the third quarter, according to its most recent filing with the SEC. The firm owned 23,220 shares of the healthcare conglomerate's stock after selling 978 shares during the period. Logan Capital Management Inc.'s holdings in UnitedHealth Group were worth $13,576,000 as of its most recent filing with the SEC.

A number of other hedge funds have also bought and sold shares of the company. State Street Corp lifted its position in shares of UnitedHealth Group by 1.3% during the 3rd quarter. State Street Corp now owns 45,540,102 shares of the healthcare conglomerate's stock valued at $26,626,387,000 after acquiring an additional 563,554 shares during the period. Geode Capital Management LLC raised its holdings in shares of UnitedHealth Group by 1.6% during the third quarter. Geode Capital Management LLC now owns 19,636,704 shares of the healthcare conglomerate's stock valued at $11,440,133,000 after purchasing an additional 318,039 shares during the period. Franklin Resources Inc. increased its position in UnitedHealth Group by 2.5% in the 3rd quarter. Franklin Resources Inc. now owns 8,061,916 shares of the healthcare conglomerate's stock valued at $4,884,019,000 after buying an additional 193,800 shares in the last quarter. Bank of New York Mellon Corp boosted its holdings in UnitedHealth Group by 0.4% in the second quarter. Bank of New York Mellon Corp now owns 8,039,601 shares of the healthcare conglomerate's stock worth $4,094,247,000 after acquiring an additional 35,533 shares in the last quarter. Finally, International Assets Investment Management LLC raised its position in shares of UnitedHealth Group by 78,814.4% during the third quarter. International Assets Investment Management LLC now owns 5,296,737 shares of the healthcare conglomerate's stock worth $3,096,896,000 after purchasing an additional 5,290,025 shares during the period. Institutional investors own 87.86% of the company's stock.

UnitedHealth Group Price Performance

Shares of UnitedHealth Group stock traded up $4.92 on Friday, hitting $520.68. 8,201,924 shares of the company traded hands, compared to its average volume of 3,987,167. The company has a market cap of $479.17 billion, a P/E ratio of 33.88, a P/E/G ratio of 1.57 and a beta of 0.58. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73. The firm's 50-day simple moving average is $583.29 and its 200 day simple moving average is $559.30.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, beating the consensus estimate of $7.00 by $0.15. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The firm had revenue of $100.82 billion for the quarter, compared to analyst estimates of $99.14 billion. During the same period in the prior year, the company earned $6.56 EPS. The company's revenue was up 9.2% on a year-over-year basis. Analysts expect that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 17th. Investors of record on Monday, December 9th will be issued a dividend of $2.10 per share. The ex-dividend date of this dividend is Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a yield of 1.61%. UnitedHealth Group's dividend payout ratio is presently 54.72%.

Analyst Upgrades and Downgrades

Several research firms have weighed in on UNH. Morgan Stanley lowered their price objective on shares of UnitedHealth Group from $615.00 to $610.00 and set an "overweight" rating on the stock in a report on Wednesday, October 16th. Cantor Fitzgerald raised their price target on shares of UnitedHealth Group from $591.00 to $644.00 and gave the company an "overweight" rating in a research report on Wednesday, October 16th. TD Cowen increased their price objective on UnitedHealth Group from $601.00 to $609.00 and gave the stock a "buy" rating in a research note on Friday, October 18th. StockNews.com upgraded UnitedHealth Group from a "hold" rating to a "buy" rating in a report on Monday. Finally, Truist Financial reaffirmed a "buy" rating and set a $625.00 price objective (down from $640.00) on shares of UnitedHealth Group in a report on Wednesday, October 16th. Three equities research analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average target price of $626.84.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.